All relevant data (mean, SD, and SE with all raw data) are shown in [S2 Table](#pone.0238223.s002){ref-type="supplementary-material"}. Raw western blot data is shown in the Supporting Information figure. The figure of tissue staining is the original image of the micrograph.

Introduction {#sec001}
============

Hypertension is a multifactorial disease caused by the interaction of genes and environment, and is a major factor in the future development of cardiovascular disease (CVD) \[[@pone.0238223.ref001], [@pone.0238223.ref002]\]. Risk factors for developing hypertension vary, but one is considered to be low birthweight (LBW). A systematic review by Huxley *et al*. found that birthweight and blood pressure are negatively correlated \[[@pone.0238223.ref003]\]. While studying the morbidity and mortality of a large cohort in the general population, Barker and colleagues found a strong association between birthweight and susceptibility to both adult onset hypertension and CVD \[[@pone.0238223.ref004]\]. Many other epidemiological and experimental studies have strongly supported the Barker's findings \[[@pone.0238223.ref005]--[@pone.0238223.ref007]\]. There is also a link between LBW and an increased risk of death of individuals from CVD who are born small and more likely to have left ventricular hypertrophy \[[@pone.0238223.ref008]\] and coronary heart disease \[[@pone.0238223.ref009]\]. Furthermore, the developmental origins of health and disease (DOHaD) theory has evolved into the idea that mismatches between the acquired constitution in utero and the postnatal growth environment create a risk of developing noncommunicable diseases \[[@pone.0238223.ref010]--[@pone.0238223.ref014]\].

In Japan, an increase in the rate of LBW infants has been reported to be remarkably elevated for over a decade, and it is an urgent task to control the future development of non-communicable chronic diseases in these children \[[@pone.0238223.ref015], [@pone.0238223.ref016]\]. However, verification of the mechanisms underlying the adult onset of hypertension caused by LBW in humans is time consuming and has many ethical problems. Therefore, we generated a model rat that was fed a low-carbohydrate and calorie-restricted diet during pregnancy. Although the rats did not deliver prematurely, the offspring weighed less and some of them failed to catch up during postnatal growth. In addition, we found that when they were exposed to restraint stress, blood corticosterone levels were further elevated due to a dysfunctional glucocorticoid-mediated feedback system in the pituitary gland \[[@pone.0238223.ref017], [@pone.0238223.ref018]\].

The mechanisms that mediate fetal programming of hypertension have been extensively studied and reviewed in three major organs or systems \[[@pone.0238223.ref019]--[@pone.0238223.ref021]\]: the kidney (decreased nephron number, activation of the renin-angiotensin system, or increased renal sympathetic nerve activity), the vasculature (alterations in structure or impaired vasodilation), and the neuroendocrine system \[hypothalamic-pituitary-adrenal (HPA) upregulation or altered adaptation to stress\]. The first causative organ responsible for hypertension is the kidney. Births of a low weight or being premature are associated with an increased risk of hypertension, proteinuria, and kidney diseases that develop later in life. Adverse events in the uterus can affect fetal kidney development and reduce the final number of nephrons \[[@pone.0238223.ref022]\]. The octapeptide angiotensin II, which is generated from angiotensin I by the angiotensin-converting enzyme, modulates blood pressure, water and sodium homeostasis, neuronal function, and other neurohumoral systems. The effects of angiotensin II are mediated by two receptors, referred to as the angiotensin II type-1 (AT1) and type-2 (AT2) receptor subtypes. The AT1 and AT2 are both G protein-coupled receptors, but AT2 shares only 34% identity with AT1 \[[@pone.0238223.ref023], [@pone.0238223.ref024]\]. AT1-receptor are expressed in vascular smooth muscle cells, heart, lung, brain, liver, kidney, adrenal glands, and others and its activation causes vasoconstriction, sodium and water retention, neurohumoral activation, and increased vascular reactive oxygen species (ROS) production. AT2 expression is found in the kidney and nervous and cardiovascular systems of adult rats \[[@pone.0238223.ref025], [@pone.0238223.ref026]\]. It has already been summarized that AT2 inhibits the AT1-mediated increase in inositol triphosphate and shows vasodilator, antifibrotic, antiproliferative, and anti-inflammatory effects \[[@pone.0238223.ref027]--[@pone.0238223.ref030]\].

The second causative organ for hypertension is the vasculature. Well-established animal models indicate that environmentally induced intrauterine growth restriction (IUGR); by diet, diabetes, hormonal exposure, or hypoxia, increases the risk of development of various diseases in target organs later in life \[[@pone.0238223.ref031]\]. This suggests that a series of perturbations in fetal and postnatal growth may influence developmental programming and produce abnormal phenotypes. The endothelium, composed of endothelial cells, may be an important player for modulating long-term remodeling and the elastic properties of arterial walls.

The third cause is the neuroendocrine system. We previously reported that LBW rats maintain elevated blood corticosterone under restraint stress \[[@pone.0238223.ref017], [@pone.0238223.ref018]\]. Therefore, we investigated whether a high-fat diet, which is a chronic metabolic stress, could increase blood corticosterone levels in LBW rats. We have already shown that pituitary miR-449a is involved in the negative feedback of glucocorticoids \[[@pone.0238223.ref032]\], and restraint stress-induced LBW rats have impaired induction of miR-449a expression in the anterior pituitary gland.

Therefore, the purpose of the present study was to clarify whether LBW caused by low carbohydrate and calorie restriction in fetuses increases blood pressure after growth, and if a mismatch between the acquired constitution in the fetal age and the postnatal growth environment further can increase~~s~~ blood pressure, and which organs are involved. To this end, we investigated the morphology of the kidneys of LBW rats and examined the number and size of glomeruli, and the expression levels of AT1 and AT2 in the abdominal aorta (one of the common sites of arteriosclerosis in humans) and heart. We also examined the relationship between blood adrenal steroid levels and blood pressure, and investigated whether pituitary glucocorticoid feedback in LBW rats is affected by high-fat diet exposure. Finally, to determine whether elevated corticosterone is responsible for increasing blood pressure, we examined whether administration of metyrapone can normalize blood pressure. Thus, we have investigated the mechanism by which hypertension occurs in LBW rats exposed to a high-fat diet.

Methods {#sec002}
=======

Animals {#sec003}
-------

Wistar rats were maintained at 23 ± 2°C with a 12:12-h light-dark cycle (lights on at 0800 h, off at 2000 h). They were allowed *ad libitum* access to laboratory chow and sterile water. All experimental procedures were reviewed and approved by the Laboratory Animals Ethics Review Committee of Nippon Medical School (\#27--067 and \#2020--003). All experiments were performed in accordance with relevant guidelines and regulations \[[@pone.0238223.ref033]\]. We previously generated fetal low-carbohydrate and calorie-restricted rats \[[@pone.0238223.ref034]\]. Briefly, twenty proestrous female rats (age, 9 weeks) were mated with normal male rats. Dams were housed individually with free access to water and were divided into two groups: low-carbohydrate and calorie-restricted diet (LC) dams were restricted in their calorie intake to 60% of the control group during the entire gestational period ([S1 Table](#pone.0238223.s001){ref-type="supplementary-material"}, D08021202, Research Diet Inc., New Brunswick, NJ), while control dams freely accessed food during the period. Twelve to twenty pups were obtained from 10 dams of each group. We excluded rat pups born with a body weight of more than 6.0 g, which is the average-2SD body weight of the offspring of normal dams. No surrogate mother was used, and 10 rat pups were left at random and raised under the birth mother rat. Postnatal mother rats were fed a standard diet *ad libitum*. After weaning, the rats of different litters were mixed. Male rats (n = 46) were divided into two groups at 5 weeks of age, one on a high-fat diet (lard-based 45kcal% fat, D12451, Research Diet) (n = 23) and the other on a standard diet (n = 23) ([Fig 1A](#pone.0238223.g001){ref-type="fig"}). At 18 weeks of age, blood pressure was measured, blood was collected, organs were removed from the rats, and gene expressions, hormone levels were analyzed.

![Experimental schema and rat weight.\
A, Schema of experimental design. Std.Chow indicates a standard diet, and LC indicates a low-carbohydrate calorie restricted diet. Below the arrows are shown the composition of the diet and the average calorie intake per day. HFD stands for high-fat diet. The graph of the birth weight of the male rat used in the experiment (B), the alteration of the weight during lactation (C), the weight before (D) and after (E) exposure to the high-fat diet (HFD) or standard chow (SC), and the body fat percentage after exposure to the HFD or SC (F) are shown. Statistical analysis was performed using unpaired T test for B, two-way ANOVA for C, and one-way ANOVA followed by Turkey\'s *post hoc* test for multiple comparisons for D-F.](pone.0238223.g001){#pone.0238223.g001}

Tissue staining {#sec004}
---------------

The abdominal aortas and kidneys of rats were removed and fixed by immersion in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 1 day at 4°C, dehydrated through a graded ethanol series, and embedded in paraffin. The sections were cut with a microtome (SM 2000 R, Leica Biosystems, Wetzlar, Germany) and placed on PLATINUM PRO slides (Matsunami, Osaka, Japan) as previously described \[[@pone.0238223.ref035]\]. For observation of the renal glomerular basement membranes, kidney sections (1 μm thick) were deparaffinized and stained with periodic acid methenamine silver (PAM). For immunohistochemistry, deparaffinized aorta sections were treated for antigen retrieval by heating in an autoclave in 1 mM EDTA at 121°C for 5 min, and were then incubated overnight at 25°C with mouse anti-α-smooth muscle (SMA) (1:200; A5228, Sigma) in phosphate-buffered saline (PBS) containing 1% bovine serum albumin. After washing with PBS, the sections were incubated with Cy3-labeled donkey anti-rabbit IgG, Alexa Fluor 488-labeled donkey anti-mouse IgG (Jackson Immunoresearch, West Grove, PA, USA), and 4',6-diamidino-2-phenylindole (DAPI; Dojindo, Kumamoto, Japan) for 2 h at room temperature. The specimens were examined with a BX53 microscope equipped with a DP80 microscope digital camera and cellSens imaging software (Olympus Optical, Tokyo, Japan).

Blood pressure and body fat measurements {#sec005}
----------------------------------------

Blood pressure was measured non-invasively from tail blood volume, flow, and pressure using a volume pressure recording sensor and an occlusion tail cuff (CODA System; Hakubatec Lifescience Solutions, Tokyo, Japan) \[[@pone.0238223.ref036]\]. As reported previously, this is a highly accurate system that can non-invasively and simultaneously measure systolic and diastolic blood pressure and heart rate \[[@pone.0238223.ref037]\]. Prior to measurement, rats were placed on a 37°C heating pad until the tail temperature reached 37°C. After heating, blood pressure was measured 10 times, and the average value was used. All measurements were performed at the same time (10:00 am to 02:30 pm). The measurement of the rat body fat percentage was performed using ImpediVET (BRC bioresearch center, Nagoya, Japan) under 4% isoflurane anesthesia.

RNA extraction and real-time RT-PCR {#sec006}
-----------------------------------

We performed mRNA and miRNA quantification as previously reported \[[@pone.0238223.ref017]\]. Total RNA was extracted from abdominal aortas, hearts, kidneys, and pituitaries using RNAiso Plus (Takara, Shiga, Japan). The absorbance of each sample at 260 nm and 280 nm was assayed, and RNA purity was judged as the 260/280 nm ratio (The 260 /280 nm ratio of all samples used in this study was higher than 1.7). For miRNA expression analysis, first-strand cDNA was synthesized at 37°C for 1 h using 500 ng of denatured total RNA and then terminated at 85°C for 5 min using a Mir-X^®^ miRNA First-Strand Synthesis and SYBR^®^ qRT-PCR kit (Clontech Laboratories Inc., Mountain View, CA). For mRNA expression analyses, first-strand cDNA was generated using 250 ng of denatured total RNA; the reaction mixture was incubated at 37°C for 15 min, 84°C for 5 sec, and 4°C for 5 min using a PrimeScript^®^ RT reagent kit with gDNA Eraser (Takara). PCR was performed by denaturation at 94°C for 5 sec and annealing-extension at 60°C for 30 sec for 40 cycles using SYBR premix Ex Taq (Takara) and specific primer sets for rat AT1 (RA061027, Takara), AT2 (RA060278, Takara), or GAPDH (RA015380, Takara). To normalize each sample for RNA content, GAPDH, a housekeeping gene, and U6 small nuclear RNA (Clontech Laboratories, Inc.) were used for mRNA and miRNA expression analyses, respectively. The 2^nd^ derivative method was used as the standard and for calculating C~t~ values, respectively \[[@pone.0238223.ref038]\].

Western blotting {#sec007}
----------------

We performed western blotting quantification as previously reported \[[@pone.0238223.ref034]\]. Protein samples from rat infrarenal aortas and hearts were extracted using complete lysis-M (Roche, Mannheim, Germany). The protein concentrations of lysate samples were determined using the Pierce 660 nm Protein assay (Thermo Scientific, Rockford, IL). Each 5 μg of protein was electrophoresed on a 5--20% gradient SuperSep^TM^ SDS-polyacrylamide gel (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) and transferred to a nitrocellulose membrane. The transfer membranes were blocked with 5% skim milk and then incubated with an anti-AT1 antibody (1:1,000, GTX89149, GeneTex, Inc., Irvine, CA) or anti-AT2 antibody (1:1,000, GTX62361, GeneTex) for 1 h at room temperature. The transfer membranes were washed with TBS-T and further incubated with HRP-labeled anti-goat or anti-rabbit IgG (1:2,000, Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. The signals were detected using SuperSignal West Dura extended duration substrate (Thermo Scientific). The membranes after detection were stripped of the antibody using Restore plus western blot stripping buffer (Thermo Scientific). Then, signals were detected again using THE^TM^ \[HRP\]-labeled β-actin antibody (1:1,000, A00730-40, GeneScript, Piscataway, NJ). The expression levels of AT1 or AT2 were quantified by correcting the AT1 or AT2 signal with the β-actin signal.

Measurement of blood aldosterone, corticosterone and leptin levels {#sec008}
------------------------------------------------------------------

Aldosterone and corticosterone levels were measured using blood plasma from decapitated rats. Aldosterone was measured using a rat aldosterone EIA kit (\#501090, Cayman Chemical, Ann Arbor, MI), corticosterone was measured using a rat corticosterone ELISA kit (\#501320, Cayman Chemical) and leptin was measured using a Mouse/Rat Leptin Quantikine ELISA kit (R&D systems, Minneapolis, MN).

Metyrapone administration {#sec009}
-------------------------

Metyrapone inhibits 11-beta-hydroxylase, thereby inhibiting synthesis of cortisol from 11-deoxycortisol and corticosterone from deoxycorticosterone in the adrenal gland. Administration of metyrapone (Sigma-Aldrich, St Louis, MO) to rats was performed according to a previous report \[[@pone.0238223.ref039]\]. Rats treated with metyrapone (10 mg/100 g body weight, s.c., twice daily at 0900 h and 1800 h for a week).

Statistical analysis {#sec010}
--------------------

Unpaired *t* tests, a one-way analysis of variance (ANOVA) followed by Turkey\'s *post hoc* test for multiple comparisons, or two-way ANOVA were used for each statistical analysis. Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA) was used for all calculations. Real-time RT-PCR and western blot data are expressed as percents ± SEM with the control set to 100. p \<0.05 was considered statistically significant.

Results {#sec011}
=======

Body weight and body fat percentage {#sec012}
-----------------------------------

There were no differences in the gestational times of the offspring or the numbers of births from LC and control dams. The average birthweight of offspring from calorie-restricted mother rats was 5.13±0.08 g (mean ± SEM, n = 58), which was significantly lower than that of control rats by 6.85±0.06 g (n = 58) ([Fig 1B](#pone.0238223.g001){ref-type="fig"}, p\<0.0001). The average birthweight of litters by mother is shown in [S2 Table](#pone.0238223.s002){ref-type="supplementary-material"}. The average bodyweight of LBW rats was low until weaning and did not increase rapidly during lactation ([Fig 1C](#pone.0238223.g001){ref-type="fig"}). The average bodyweight of offspring from calorie-restricted mother rats before high-fat diet exposure (5 weeks old) was 118.5±2.2 g (n = 23), which was significantly lower than that of control rats by 130.6±2.0 g (n = 23) ([Fig 1D](#pone.0238223.g001){ref-type="fig"}, p\<0.005). The bodyweight of LBW rats after high-fat diet exposure (18 weeks old) was 554.0±11.0 g (n = 23), which was significantly lower than that of control rats exposed to high-fat diet, 641.7±11.7 g (n = 23) ([Fig 1E](#pone.0238223.g001){ref-type="fig"}, p\<0.001). The bodyweight of LBW rats on standard diet was not statistically different from NBW rats on standard diet. Similarly, the body fat percentage of LBW rats after high-fat diet exposure was 38.6±0.7% (n = 15), which was significantly less than the body fat percentage of NBW rats exposed to high-fat diet 44.8±0.9% (n = 15) ([Fig 1F](#pone.0238223.g001){ref-type="fig"}, p\<0.01).

Blood pressure {#sec013}
--------------

The blood pressure of rats fed the standard diet showed a slight but not significant increase in both systolic (110.9±2.5 vs. 120.2±3.9 mmHg, 18-week-old NBW vs. 18-week-old LBW, respectively, mean ± SEM, n = 15, p\>0.05) and diastolic pressure (83.0±1.7 vs. 89.2±2.7 mmHg, NBW vs. LBW, respectively, n = 15, p\>0.05) in LBW rats compared with control rats ([Fig 2A](#pone.0238223.g002){ref-type="fig"}). When rats were exposed to a high-fat diet, the systolic (133.3±2.2 vs. 151.1±2.5 mmHg, NBW vs. LBW, respectively, n = 15, p\<0.001) and diastolic pressures (89.8±2.2 vs. 104.7±1.6 mmHg, NBW vs. LBW, respectively, n = 15, p\<0.001) of LBW rats were significantly higher than those of control rats ([Fig 2B](#pone.0238223.g002){ref-type="fig"}).

![Blood pressure and tissue observations of kidneys and aortas of LBW rats with high-fat diet exposure.\
LBW rats were exposed to a high-fat diet (HFD) for 8 weeks. Blood pressure was measured by the tail-cuff method. (A) shows control rats (NBW) and LBW rats fed a standard chow, and (B) shows control rats and LBW rats exposed to a high-fat diet (n = 15). Statistical analysis was performed using unpaired T-test. Characteristic kidney PAM staining image and an aortic anti-SMA immunostaining image are shown (C and D).](pone.0238223.g002){#pone.0238223.g002}

Renal glomerular morphology and aortic vascular smooth muscle staining {#sec014}
----------------------------------------------------------------------

The kidneys of LBW rats and control rats exposed to a high-fat diet were excised and subjected to PAM staining. There was no difference in the number of glomeruli per field of view of the glomeruli (5.8±0.2, 5.9±0.5, 5.8±0.2 and 5.6±0.2 glomeruli/field of view in standard chow-fed NBW, standard chow-fed LBW, high-fat diet-exposed NBW and high-fat diet-exposed LBW, respectively, no significance), leading to no identification of glomerular hypertrophy, glomerular injury with mesangial proliferation, or matrix deposition ([Fig 2C](#pone.0238223.g002){ref-type="fig"}). Similarly, aortic smooth muscle was stained with anti-SMA antibody, but no difference was found in smooth muscle thickness among them ([Fig 2D](#pone.0238223.g002){ref-type="fig"}).

Angiotensin II receptor expression {#sec015}
----------------------------------

The expression levels of angiotensin II receptors (AT1 and AT2) in aortas and hearts were examined by real-time RT-PCR and western blotting. The expressions of mRNA and protein of AT1 in the aortas (53.4±2.0%, p\<0.005 for mRNA and 83.5±1.7%, p\<0.05 for protein, n = 8) and hearts (42.9±2.3%, p\<0.001 for mRNA and 49.3±1.9%, p\<0.001 for protein, n = 8) of LBW rats fed the standard diet were significantly lower than those in controls, respectively (Figs [3A](#pone.0238223.g003){ref-type="fig"}, [3C](#pone.0238223.g003){ref-type="fig"}, [4A and 4C](#pone.0238223.g004){ref-type="fig"}). When a high-fat diet was provided, the expressions of mRNA and protein of AT1 in the aortas (23.4±1.1%, p\<0.005 for mRNA and 56.1±1.3, p\<0.005 for protein, n = 8) and hearts (27.9±4.5%, p\<0.01 for mRNA and 31.3±1.4%, p\<0.001 for protein, n = 8) of high-fat diet-exposed LBW rats were significantly lower than those in standard chow-fed LBW rats, respectively (Figs [3A](#pone.0238223.g003){ref-type="fig"}, [3C](#pone.0238223.g003){ref-type="fig"}, [4A and 4C](#pone.0238223.g004){ref-type="fig"}). While the expression of AT2 in the aortas of LBW rats fed a standard diet was lower than that in the controls (67.1±5.7%, p\<0.005 for mRNA and 83.3±3.3%, p\<0.01 for protein, n = 8) ([Fig 3B and 3D](#pone.0238223.g003){ref-type="fig"}), the expression of AT2 in the hearts of LBW rats fed a standard diet was higher than that in the controls (186.2±17.0%, p\<0.01 for mRNA and 207.9±8.3%, p\<0.001 for protein, n = 8) ([Fig 4B and 4D](#pone.0238223.g004){ref-type="fig"}). Exposure to a high-fat diet reduced their expression in the aorta (28.1±1.8%, p\<0.005 for mRNA and 57.4±3.6%, p\<0.005 for protein, n = 8) ([Fig 3C and 3D](#pone.0238223.g003){ref-type="fig"}). The protein expression of AT2 in the heart of high-fat diet-exposed LBW was significantly increased compared with that of standard chow-fed LBW (234.0±7.7%, p\<0.05, n = 8) ([Fig 4D](#pone.0238223.g004){ref-type="fig"}).

![Expression of angiotensin receptor in the aorta.\
The mRNA expression levels of AT1 (A) and AT2 (B) and protein expression levels of AT1 (C) and AT2 (D) in the aortas of control rats (NBW) or LBW rats exposed to a standard chow (Std.Chow) or high-fat diet (HFD) were quantified. The mRNA expression level is a ratio obtained by correcting the ΔΔCT values of AT1 or AT2 with the ΔΔCT values of GAPDH and setting the value of Std.Chow-fed NBW to 100. The protein expression level is a ratio obtained by correcting the signal of AT1 or AT2 with the signal of ß-actin and setting the value of Std.Chow-fed NBW to 100. n = 8. Statistical analysis was performed using one-way ANOVA followed by Turkey\'s *post hoc* test for multiple comparisons.](pone.0238223.g003){#pone.0238223.g003}

![Expression of angiotensin receptor in the heart.\
The mRNA expression levels of AT1 (A) and AT2 (B) and protein expression levels of AT1 (C) and AT2 (D) in the hearts of control rats (NBW) or LBW rats exposed to a standard chow (Std.Chow) or high-fat diet (HFD) were quantified. The mRNA expression level is a ratio obtained by correcting the ΔΔCT values of AT1 or AT2 with the ΔΔCT values of GAPDH and setting the value of Std.Chow-fed NBW to 100. The protein expression level is a ratio obtained by correcting the signal of AT1 or AT2 with the signal of ß-actin and setting the value of Std.Chow-fed NBW to 100. n = 8. Statistical analysis was performed using one-way ANOVA followed by Turkey\'s *post hoc* test for multiple comparisons.](pone.0238223.g004){#pone.0238223.g004}

Blood hormone levels {#sec016}
--------------------

Blood aldosterone and corticosterone levels in LBW rats fed a standard diet did not differ from those of control rats ([Fig 5](#pone.0238223.g005){ref-type="fig"}). When a high-fat diet was given to LBW rats, blood corticosterone levels increased significantly compared to control rats (684.3±23.8 ng/ml and 333.1±11.3 ng/ml, high-fat diet-exposed LBW and high-fat diet-exposed NBW, respectively, p\<0.005, n = 7), but blood aldosterone levels did not differ between the two groups. Blood leptin levels did not differ between NBW (447.4±47.7 pg/ml) and LBW (455.0±48.7 pg/ml) rats fed a standard diet. The high-fat diet significantly increased leptin levels in NBW rats (3047±773.0 pg/ml, p\<0.01 vs. Std.Chow, n = 6) compared to standard chow-fed NBW rats, but not significantly in LBW (1193±359.0 pg/ml).

![Blood aldosterone, corticosterone and leptin levels.\
Plasma concentrations of aldosterone (A), corticosterone (B) and leptin (C) of control rats (NBW) or LBW rats exposed to a standard chow or high-fat diet (HFD) were measured. Statistical analysis was performed using one-way ANOVA followed by Turkey\'s *post hoc* test for multiple comparisons.](pone.0238223.g005){#pone.0238223.g005}

Expression of miR-449a in the anterior pituitary {#sec017}
------------------------------------------------

The expression of miR-449a in the pituitary glands of rats fed a standard diet was not different between control and LBW rats ([Fig 6](#pone.0238223.g006){ref-type="fig"}). When a high-fat diet was given, pituitary miR-449a was increased compared to the standard diet in controls (220.6±8.2% of control, p\<0.001, n = 7); however, in LBW rats there was no increase in miR-449a with high-fat diet exposure (122.4±3.3% of control, p\>0.05, n = 7).

![Expression of miR-449a in the anterior pituitary.\
Expression of miR-449a in the anterior pituitary of control rats (NBW) or LBW rats exposed to a standard chow (Std.Chow) or high-fat diet (HFD) were quantified. The miRNA expression level is a ratio obtained by correcting the ΔΔCT values of miR-449a with the ΔΔCT values of U6 and setting the value of Std.Chow-fed NBW to 100. n = 7. Statistical analysis was performed using one-way ANOVA followed by Turkey\'s *post hoc* test for multiple comparisons.](pone.0238223.g006){#pone.0238223.g006}

Administration of steroid synthesis inhibitors {#sec018}
----------------------------------------------

Administration of metyrapone to 18-week-old LBW rats exposed to a high-fat diet significantly reduced the levels of corticosterone (70.8±14.7 ng/ml for metyrapone and 679.0±26.8 ng/ml for vehicle, p\<0.001, n = 6) and aldosterone (51.0±5.9 ng/ml for metyrapone and 233.8±12.3 ng/ml for vehicle, p\<0.001, n = 6), respectively, which were elevated by the high-fat diet ([Fig 7A and 7B](#pone.0238223.g007){ref-type="fig"}). Metyrapone significantly reduced the upregulation of blood pressure in LBW rats to levels comparable with control rats ([Fig 7C and 7D](#pone.0238223.g007){ref-type="fig"}). Administration of metyrapone to control rats did not produce different results from vehicle administration.

![Changes in blood pressure after administration of steroid synthesis inhibitors.\
Blood corticosterone (A) and aldosterone (B) concentrations were measured in rats treated with metyrapone. The blood pressure of control rats (NBW) and LBW rats exposed to the high-fat diet (HFD) after the administration of metyrapone or vehicle was measured by the tail cuff method. The systolic pressure (C) and the diastolic pressure (D) of each rat are shown. n = 6. Statistical analysis was performed using one-way ANOVA followed by Turkey\'s *post hoc* test for multiple comparisons.](pone.0238223.g007){#pone.0238223.g007}

Discussion {#sec019}
==========

In our rat model, elevated corticosterone levels (with renal sodium reabsorption) following exposure to a high-fat diet may be the main contributing factor for increased blood pressure in LBW rats. The expression of AT1, which is involved in increasing blood pressure by vasoconstriction, also decreased and AT2 expression, which is involved in decreasing blood pressure by vasodilation, was increased. These results suggest that the pattern of altered expression in the heart may be a compensatory change in blood pressure. Thus, all results, including the absence of pathological findings in the kidney and aorta as well as the elevation of blood aldosterone levels, indicated that renal and vascular diseases may not play a causative role in the development of hypertension in our full-term fetal low-carbohydrate and calorie-restricted rat model.

It has been reported that premature babies have low nephron numbers because the formation of renal glomeruli depends on the embryonic period. In our model, there was no difference in gestational age, as previously reported \[[@pone.0238223.ref034]\], and only birthweight was decreased. In fact, there was no difference in the weights of kidneys per body weight, and histological analysis of the kidney showed no differences in the number of glomeruli per visual field or in the morphological appearance. These findings suggest that the mechanism may potentially differ from the development of hypertension often seen in preterm infants. Furthermore, since the expression of AT1 was decreased in the hearts and aortas of high-fat diet-exposed LBW rats, these are considered to be compensatory changes. Although aldosterone levels in the blood increased with a high-fat diet compared to the standard chow, there was no difference between LBW and control rats. Moreover, there was no difference in heart rate. Although we did not investigate the functions of the autonomic nervous system, we consider that the involvement of the sympathetic nervous system may not be taken into account.

Protein intake is the key to increased blood pressure caused by fetal malnutrition. Maternal protein restriction during pregnancy has been reported to result in kidney abnormalities (decreased nephron number and glomerular morphology) and an increased renin-angiotensin system. Fujii *et al*. report that a 30% dietary restriction during pregnancy results in increased blood pressure in rat offspring, but branched-chain amino acid supplementation normalized it \[[@pone.0238223.ref040]\]. Allen and Zeman suggest that the progeny of protein-deficient rats show a permanent retardation in kidney development which is not reversed by increased postnatal nutrient intake \[[@pone.0238223.ref041]\]. On the contrary, postnatal high protein diet amplifies the renal damage induced by fetal undernutrition \[[@pone.0238223.ref042]\]. Those results show that the amino acids consumed by the mother are important for the formation of the fetal and postnatal kidney. The effects of nutrients on nephron formation, especially the effects of placenta-mediated amino acids, need to be investigated. However, in our results, these abnormalities were not observed in a fetal low-carbohydrate calorie-restriction model. Elevated blood pressure in LBW rats exposed to a high-fat diet may not be related to renal nephron hypoplasia. Although detailed alteration of metabolites from low-carbohydrate and calorie-restriction exposure needs to be investigated in the near future, we have shown that the mechanisms of hypertension are different between protein-restriction and carbohydrate-restriction.

Singal *et al*. reviewed that atherosclerosis has a long preclinical stage in which pathological changes appear in the arteries of children and young adults before overt clinical manifestations of the disease appear \[[@pone.0238223.ref043]\]. Both fetal and childhood nutrition is important in this process and has been shown to affect the risk of lifelong CVD (e.g. breastfeeding is associated with long-term cardiovascular risk factors). It has been reported that fetal high-density lipoprotein cholesterol (HDL-C) and total cholesterol (TC) levels are lower in IUGR, and that the atherogenic index is increased in IUGR compared to healthy neonates \[[@pone.0238223.ref044]\]. Arteriosclerosis is an inflammatory disease, and its onset is known to involve excessive LDL-C \[[@pone.0238223.ref045]\] but may also involve a decrease in HDL-C. Because of the anti-inflammatory properties of HDL-C, a decrease in HDL-C during fetal development and an increase in atherogenic index may be involved in the future development of arteriosclerosis in IUGR children. Although we have not examined the blood lipid profile of this rat model, we did not observe thickening of vascular smooth muscle in the aorta. Furthermore, we found that the expression of AT2 was increased in the hearts of high-fat diet-exposed LBW rats compared to controls, but not in the aortas. AT2 is involved in the regulation of remodeling \[[@pone.0238223.ref030]\]. In the present study, the aortas of high-fat diet-exposed LBW rats may not have been damaged. However, future studies are needed to clarify that the details of the mechanisms underlying increase in AT2R expression and changes in the blood pressure control system that occur when AT2R expression is blocked. In fact, there is a report indicating that a major risk factor for the development of arteriosclerosis as well as hypertension is preterm birth, and the risk of that in full-term small for gestational age (SGA) children is not high \[[@pone.0238223.ref046]\]. Therefore, it is unlikely that atherosclerosis is not a principal cause for hypertension observed in our model.

Previous studies have reported that basal blood glucocorticoid levels in offspring are elevated by various factors, such as embryonic protein deficiency \[[@pone.0238223.ref047]\], maternal obesity \[[@pone.0238223.ref048], [@pone.0238223.ref049]\], prenatal stress \[[@pone.0238223.ref050], [@pone.0238223.ref051]\], and early life stress (including early weaning and maternal separation) \[[@pone.0238223.ref052]--[@pone.0238223.ref054]\]. The steroid synthesis inhibitor metyrapone normalized the abnormalities caused by glucocorticoids \[[@pone.0238223.ref055], [@pone.0238223.ref056]\]. Our embryonic low-carbohydrate, calorie restricted diet did not affect the basal blood corticosterone levels in offspring, but significantly increased after a high-fat diet exposure. The difference from the previous reports that affect the basal level of glucocorticoid is considered to be that embryonic hypoglycemic stress is relatively mild stress. The Predictive adaptive response hypothesis is thought to make a trade-off that alters the metabolic and endocrine systems to protect brain size \[[@pone.0238223.ref057]\]. It can be thought that the brain was protected by a trade-off in the mild stress of sugar restriction of dams. However, when a mismatch such as a high-fat diet occurs, it is possible that the abnormality cannot be withstood and the abnormality appears. Therefore, it is speculated that the basal blood corticosterone concentration was not affected and showed high level after a high-fat diet exposure. In the future, it is necessary to investigate the mechanism that causes embryonic programming of glucocorticoid feedback due to the difference in stress intensity.

Excess glucocorticoids often survive inactivation by 11β-hydroxysteroid dehydrogenase-2 in the kidney and bind to mineralocorticoid receptors. As a result, blood pressure increases due to sodium reabsorption and increased fluid volume. Ingestion of a high-fat diet or obesity results in metabolic stress, leading to an increase in blood glucocorticoids \[[@pone.0238223.ref058], [@pone.0238223.ref059]\]. Excessive and prolonged glucocorticoid exposure is associated with a high cardiovascular and metabolic burden. Chronic hypercortisolemia causes more persistent visceral fat accumulation than high-fat diet-induced obesity \[[@pone.0238223.ref060]\]. Thus, prolonged exposure to high-fat diets can generate a negative loop of metabolic disease. We have previously reported that LBW rats show long-term high blood corticosterone after restraint stress, and that corticotropin releasing factor receptor (CRF-R1) fails to downregulate without inducing miR-449a expression in the pituitary gland \[[@pone.0238223.ref017], [@pone.0238223.ref018]\]. Since pituitary miR-449a is induced by glucocorticoids and downregulates CRF-R1 expression, miR-449a is thought to be one of the mechanisms of negative feedback of the HPA-axis by glucocorticoids. In the present study, we showed that blood corticosterone levels in high-fat diet-exposed LBW rats were higher than that in control rats. Pituitary miR-449a is induced in high-fat diet-exposed control rats compared to standard diet-fed control rats, but miR-449a did not increase in high-fat diet-exposed LBW rats, and the mechanism is unknown. In addition, we have shown that administration of steroid synthesis inhibitors to high-fat diet-exposed LBW rats normalized their blood pressure. These results suggest that LBW rats may have abnormal pituitary glucocorticoid feedback of the HPA-axis due to metabolic stress induced by high-fat diet exposure, and blood pressure may have increased due to the increased blood corticosterone concentration.

In conclusion, we found that the mechanism of elevated blood pressure in high-fat diet-exposed LBW rats is associated with abnormal glucocorticoid negative feedback due to increased miR-449a expression in the pituitary. There are various causes of the risk of developing hypertension due to LBW, but it is necessary to develop a treatment strategy for hypertension for each cause of LBW. One of the mechanisms of hypertension in high-fat diet-exposed LBW is suggested to be related to elevated blood corticosterone levels in our model rats. We think that the mismatch between the acquired constitution by undernutrition and the environment induced by a high-fat diet after growth increases the risk of developing metabolic disease. Our results imply that LBW children resulting from low-carbohydrate and calorie-restricted diets in mothers should be carefully followed in terms of evaluating their blood cortisol levels.
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AT1

:   angiotensin II type 1

AT2

:   angiotensin II type 2

CVD

:   cardiovascular disease

CRF

:   corticotropin-releasing factor

DOHaD

:   developmental origins of health and disease

HFD

:   high-fat diet

HPA

:   hypothalamic-pituitary-adrenal

IUGR

:   intrauterine growth restriction

LBW

:   low birthweight

LC

:   low-carbohydrate and calorie-restricted diet

PAM

:   periodic acid methenamine silver

SGA

:   small for gestational age

SMA

:   α-smooth muscle
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1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: No

Reviewer \#2: Yes
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2\. Has the statistical analysis been performed appropriately and rigorously?
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Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes
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5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This study investigated the mechanisms by which LBW full term causes increased BP.

Comments to the authors:

Abstract:

The abstract states that the mechanisms linking BW and BP are unknown for full-term LBW. Yet, numerous studies using different experimental models of LBW that do not deliver preterm including models of DOHaD induced via placental insufficiency, fetal exposure to GCs or maternal nutrient restriction (Langley-Evans, Baum, Wlodek, Vehaskari, Zambrano, Alexander, Rose, and Woods to name just a few) report important roles for the RAS, SNS, ET, GCs and ROS. Thus, this statement is misleading.

What is the rational for use of metyrapone, for study of miR-449a?

Overall, the abstract could provide better rationale for the study.

Cite the degree of nutrient restriction; source of carbohydrates in the prenatal diet. What is the percent fat and source of fat in the high fat diet?

Introduction:

Cites reviews not actual research papers for background. If citing reviews, then state as such.

Methods:

Details related to diets are absent, grossly limited and make it hard to compare this study to other studies. It is well-established that subtle differences in micro- and macro-nutrients during development can lead to significant differences in phenotypic outcomes.

Use of tail cuff for measurement of BP is not the gold standard and is well-established to demonstrate stress-induced BP. Why was BP not confirmed using a direct method?

Use of acid maceration is not the gold standard for detecting differences in nephron number (Bertram JF. Kid Internal. 2001).

How many dams provided offspring? Was only one offspring per sex per litter per dietary exposure utilized for each study parameter? This is critical to ensure that studies are not reporting litter effects versus a programming effect.

Antibodies for detection of Ang II receptors lack specificity (Herrera et al. Hypertension 2013;61:253.)

Why were Ang II components not studied within the kidney?

Results:

The authors state this is a non-preterm model. Did gestational length differ? Why was this not tested?

For body weight, provide ages at time of data presentation; add this to the text of the results.

N=50 and N=59? Break values into those LBW remaining on a normal diet versus those switched to the high fat diet; ditto for NBW. Thus 4 groups with smaller N.

Yet, why are only 15 and 15 rats per LBW and NBW on high and normal diet used, only a total of 30 for LBW and 30 for NBW? What happened to the other 20 and 29 rats?

Blood pressure: state age at time of measurement in the text of the results?

Related studies not considered that show that blockade of GC synthesis in models of DOHaD:

Murphy et al AJP: Endo Metab 2016;312:E98, ELS and obesity, role of GCs using metyrapone

Reviewer \#2: In this manuscript, the authors present the outcome of experiments designed to show that LBW rats (generated from fetal low-carbohydrate and calorie-restricted maternal diet) had significantly higher blood pressure than controls when exposed to a high-fat diet as newborns. No observed changes in nephron number or size were reported; however, aortic and cardiacangiotensin II receptor expression was altered. Blood hormone analysis shows no changes in aldosterone, but corticosterone levels were elevated in high-fat diet fed newborns, with metyrapone treatment inhibiting the elevation in blood pressure. The authors further report that that high-fat diet exposure causes impairment of the pituitary glucocorticoid feedback via miR-449a. The study is an extension to their previously published work utilizing the same fetal programming model which showed a heightened glucocorticoid response in response to restraint stress, suggesting dysfunctional glucocorticoid-mediated feedback system in the pituitary gland. The authors have also previously shown that pituitary miR-449a is involved in the negative feedback of glucocorticoids, and restraint stress-induced LBW rats have impaired induction of miR-449a expression in the anterior pituitary gland. The current study shows that high fat diet, similar to restraint stress have impaired miR-449a expression, which would not be surprising, considering that a reduction in miR-449 is pre-programmed by the LBW as they have previously reported. I do have some concerns and these are outlined below.

1\. Number of animals used in the study should be clearly described. How many female animals were used for breeding, how many offsprings were used from each litter and how were they assigned for each study/experimental analysis?

2\. It is surprising that the body weight of LBW rats on standard diet was not statistically different from NBW rats on standard diet. Can the authors provide an explanation, as this is different from previous reported observations in similar programming models.

3\. What is the interpretation and significance of the finding that AT2R is elevated in both LBW and NBW following high fat diet?

4\. A number of animal models/studies (high fat diet, caloric restriction, hypoxia, maternal stress, etc.) would suggest and have shown elevated levels of glucocorticoids postnatally and is the key mediator of in utero programming and has been shown to be elevated in LBW offsprings; however it appears that low carb/caloric restriction model used by the authors does not show differences in blood cort levels between LBW and NBW animals. Please elaborate in discussion as to the difference in findings, and it's relevance; however, it is intriguing that the authors are showing elevated aldosterone levels in LBW. Similarly, it is interesting that the low carb/caloric restriction model does not show increased BP in LBW compared to NBW; however, it does show an increase following restraint stress (previously published) and now HFD. The authors should highlight the significance of these observations relevant to current literature and the model used may be different than other models used to study DoHAD, and how the current model is relevant to human studies/patients..

5\. Although the authors demonstrate that glucocorticoids is involved in increased BP induced by postnatal high-fat diet in LBW newborns, these findings are not new, as glucocorticoids have been widely reported to be involved in programming of hypertension in adult animal studies..

6\. The authors report the absence of pathological findings in the kidney and aorta as well as the elevation of blood aldosterone levels, indicated that renal and vascular diseases may not play a causative role in the development of hypertension in fetal low-carbohydrate and calorie-restricted rats. A potential mechanism for increased BP should be discussed in light of the negative findings in the renal and vasculature, considering the findings are contrary to what is observed in premature babies and other models of programming.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer \#1: This study investigated the mechanisms by which LBW full term causes increased BP.

Comments to the authors:

Abstract: The abstract states that the mechanisms linking BW and BP are unknown for full-term LBW. Yet, numerous studies using different experimental models of LBW that do not deliver preterm including models of DOHaD induced via placental insufficiency, fetal exposure to GCs or maternal nutrient restriction (Langley-Evans, Baum, Wlodek, Vehaskari, Zambrano, Alexander, Rose, and Woods to name just a few) report important roles for the RAS, SNS, ET, GCs and ROS. Thus, this statement is misleading.

\>According to the reviewer's comment, we have revised the abstract text.

What is the rational for use of metyrapone, for study of miR-449a?

\>We reported in a previous paper that glucocorticoids increased miR-449a expression. Therefore, we believe that the increased expression of miR-449a suppresses the expression of Crhr1 and causes negative feedback of glucocorticoid. The elevated blood pressure in our model rat is due to high levels of corticosterone, and miR-449a does not directly affect suppression of blood pressure. Thus, in this paper, there is no relationship between expression of miR-449a and metyrapone.

Overall, the abstract could provide better rationale for the study.

\>According to the reviewer's comment, we have revised the abstract text.

Cite the degree of nutrient restriction; source of carbohydrates in the prenatal diet. What is the percent fat and source of fat in the high fat diet?

\>According to the reviewer's comment, we\'ve added details on calorie-restricted (60% of standard chow) and high-fat diets (lard-based 45kcal% fat).

Introduction: Cites reviews not actual research papers for background. If citing reviews, then state as such.

\>According to the reviewers\' comments, we removed some of the reviews cited and stated that the remaining review.

Methods: Details related to diets are absent, grossly limited and make it hard to compare this study to other studies. It is well-established that subtle differences in micro- and macro-nutrients during development can lead to significant differences in phenotypic outcomes.

\>We showed a schematic of the diets fed to the dams in Fig 1A, but provided the details as a supplementary table 1.

Use of tail cuff for measurement of BP is not the gold standard and is well-established to demonstrate stress-induced BP. Why was BP not confirmed using a direct method?

\>As the reviewer's comment, we understand that it is better to use a telemetry system. Unfortunately, however, our laboratory did not have a telemetry system, and we were unable to perform measurements on rats in long-term care. We prepared the environment for measurement of blood pressure and showed the data with little variation by performing measurement 10 times or more in the same rat.

Use of acid maceration is not the gold standard for detecting differences in nephron number (Bertram JF. Kid Internal. 2001).

\>As the reviewer's comment, we understand that acid maceration can provide a quick and reliable estimate of nephron counts throughout the kidney. Since we also observed the nephron structure, we stained with the PAM method. Since no abnormalities were found in the number and structure of nephrons in this study, only the results of PAM staining are shown.

We have shown that high salt exposure in our LBW rats cause polyuria and elevated blood pressure. In a follow-up report that will be compiled in the near future, we will explain the results of kidney analysis by comparing them with the high-fat diet exposure.

How many dams provided offspring? Was only one offspring per sex per litter per dietary exposure utilized for each study parameter? This is critical to ensure that studies are not reporting litter effects versus a programming effect.

\>In this study, 12 to 20 rat pups were obtained from each of 10 dams. We excluded pups born with a body weight of more than 6.0 g, which is the average-2SD body weight of the offspring of normal dams. No surrogate mother was used, and 10 rat pups were left at random and raised under the birth mother rat. After weaning, the rats of different litters were mixed and randomly divided into a high fat diet exposure group and a standard diet feeding group for use in the experiment. According to the reviewer's comment, we\'ve added details in method section.

Antibodies for detection of Ang II receptors lack specificity (Herrera et al. Hypertension 2013;61:253.)

\>The antibody used in this manuscript may lack specificity, as the reviewer commented. However, since it showed the same pattern as mRNA expression and a different expression pattern from AT1R, we determined that we could obtain or detect the alterations in ATR2 expression.

Why were Ang II components not studied within the kidney?

\>We have found that high fat diet-exposed LBW decreased AT1R mRNA expression and increased AT2R mRNA expression in the kidney as shown in the heart. However, when LBW was exposed to a high salt diet, renal AT1R mRNA expression was significantly increased compared to control rats exposed to a high fat diet. As mentioned above, polyuria and elevated blood pressure are seen in high salt diet-exposed LBW. Unlike the high-fat diet exposure, it was suggested that the kidney is involved in the high salt exposure, so we are preparing a follow-up report. The expressions of AT1R and AT2R in the kidney will be reported in a follow-up report comparing high fat and high salt diet exposures.

Results: The authors state this is a non-preterm model. Did gestational length differ? Why was this not tested?

\>As previously reported by Sci Rep (2020), there was no difference in gestational age. We have added this to the results.

For body weight, provide ages at time of data presentation; add this to the text of the results.

\>According to the reviewer's comment, we have added the age of the rats to the text.

N=50 and N=59? Break values into those LBW remaining on a normal diet versus those switched to the high fat diet; ditto for NBW. Thus 4 groups with smaller N.

Yet, why are only 15 and 15 rats per LBW and NBW on high and normal diet used, only a total of 30 for LBW and 30 for NBW? What happened to the other 20 and 29 rats?

\>In this study, we used 15 rats of each group to measure blood pressure, 8 rats of each group to analyze blood hormones and mRNA expression, and 6 rats of each group to measure blood pressure after administration of metyrapone (We used the same rat for blood pressure measurement and hormone concentration measurement after administration of metyrapone.) The graph of birth weight in Fig. 1B was revised because the data of birthweight of the rat used for the administration of metyrapone were missing. In addition, we have revised the total number of animals in Fig. 1D and Fig. 1E.

Blood pressure: state age at time of measurement in the text of the results?

\>According to the reviewer's comment, we have added the age of the rats to the text.

Related studies not considered that show that blockade of GC synthesis in models of DOHaD: Murphy et al AJP: Endo Metab 2016;312:E98, ELS and obesity, role of GCs using metyrapone.

\>Thank you for presenting the paper. According to the reviewer\'s comments, we have added the following text to the discussion and cited the paper in this section.

Previous studies have reported that basal blood glucocorticoid levels in offspring are elevated by various factors, such as preterm birth, embryonic protein deficiency, prenatal stress, and early postnatal stress (early weaning and maternal separation). The steroid synthesis inhibitor metyrapone normalized the abnormalities caused by glucocorticoids. Our embryonic low-carbohydrate, calorie restricted diet did not affect the basal blood corticosterone levels in offspring, but significantly increased after a high-fat diet exposure. The difference from the previous reports that affect the basal level of glucocorticoid is considered to be that embryonic hypoglycemic stress is relatively mild stress. "The Predictive adaptive response hypothesis" is thought to make a trade-off that alters the metabolic and endocrine systems to protect brain size. It can be thought that the brain was protected by a trade-off in the mild stress of sugar restriction of dams. However, when a mismatch such as a high-fat diet occurs, it is possible that the abnormality cannot be withstood and the abnormality appears. Therefore, it is speculated that the basal blood corticosterone concentration was not affected and showed a high level after a high-fat diet. In the future, it is necessary to investigate the mechanism that causes embryonic programming of glucocorticoid feedback due to the difference in stress intensity.

Reviewer \#2: In this manuscript, the authors present the outcome of experiments designed to show that LBW rats (generated from fetal low-carbohydrate and calorie-restricted maternal diet) had significantly higher blood pressure than controls when exposed to a high-fat diet as newborns. No observed changes in nephron number or size were reported; however, aortic and cardiac angiotensin II receptor expression was altered. Blood hormone analysis shows no changes in aldosterone, but corticosterone levels were elevated in high-fat diet fed newborns, with metyrapone treatment inhibiting the elevation in blood pressure. The authors further report that that high-fat diet exposure causes impairment of the pituitary glucocorticoid feedback via miR-449a. The study is an extension to their previously published work utilizing the same fetal programming model which showed a heightened glucocorticoid response in response to restraint stress, suggesting dysfunctional glucocorticoid-mediated feedback system in the pituitary gland. The authors have also previously shown that pituitary miR-449a is involved in the negative feedback of glucocorticoids, and restraint stress-induced LBW rats have impaired induction of miR-449a expression in the anterior pituitary gland. The current study shows that high fat diet, similar to restraint stress have impaired miR-449a expression, which would not be surprising, considering that a reduction in miR-449 is pre-programmed by the LBW as they have previously reported. I do have some concerns and these are outlined below.

1\. Number of animals used in the study should be clearly described. How many female animals were used for breeding, how many offsprings were used from each litter and how were they assigned for each study/experimental analysis?

\>In this study, 12 to 20 rat pups were obtained from 10 dams of each group. We excluded pups born with a body weight of more than 6.0 g, which is the average-2SD body weight of the offspring of normal dams. No surrogate mother was used, and 10 rat pups were left at random and raised under the birth mother rat. After weaning, the rats of different litters were mixed and randomly divided into a high fat diet exposure group and a standard diet feeding group for use in the experiment.

In this study, we used 15 rats of each group to measure blood pressure, 8 rats of each group to analyze blood hormones and mRNA expression, and 6 rats of each group to measure blood pressure after administration of metyrapone (We used the same rat for blood pressure measurement and hormone concentration measurement after administration of metyrapone.) The graph of birth weight in Fig. 1B was revised because the data of birthweight of the rat used for the administration of metyrapone were missing. In addition, we have revised the total number of animals in Fig. 1D and Fig. 1E.

2\. It is surprising that the body weight of LBW rats on standard diet was not statistically different from NBW rats on standard diet. Can the authors provide an explanation, as this is different from previous reported observations in similar programming models.

\>Approximately 90% of low birth weight rats catch-up by the weaning period, and have an average weight similar to that of control rats. In the previous report on Scientific Reports (2020), we collected and analyzed rats that did not catch-up by the weaning period, but this time we analyzed collectively with or without catch-up. In our preliminary experiment, the blood pressure of LBW with high fat diet exposure was higher than that of control rats with high fat diet, with or without catch-up growth. Therefore, in this paper, we presented the results that include the results of the catch-up rats. (Because only 10% of the rats do not catch-up, it is difficult to prepare a number for use in various experiments.)

3\. What is the interpretation and significance of the finding that AT2R is elevated in both LBW and NBW following high fat diet?

\>Since AT2R has vasodilatory and hypotensive effects, it is considered that the increased expression of AT2R in high-fat diet-exposed rats is the compensatory effect. We think that the details of the underlying mechanisms require further study, by which increase in AT2R expression and changes in the blood pressure control system that occur when AT2R expression is blocked. We have added these points to the discussion section.

4\. A number of animal models/studies (high fat diet, caloric restriction, hypoxia, maternal stress, etc.) would suggest and have shown elevated levels of glucocorticoids postnatally and is the key mediator of in utero programming and has been shown to be elevated in LBW offspring; however, it appears that low carb/caloric restriction model used by the authors does not show differences in blood cort levels between LBW and NBW animals. Please elaborate in discussion as to the difference in findings, and it's relevance; however, it is intriguing that the authors are showing elevated aldosterone levels in LBW. Similarly, it is interesting that the low carb/caloric restriction model does not show increased BP in LBW compared to NBW; however, it does show an increase following restraint stress (previously published) and now HFD. The authors should highlight the significance of these observations relevant to current literature and the model used may be different than other models used to study DoHAD, and how the current model is relevant to human studies/patients.

\>According to the reviewer\'s comments, we have added the following to the discussion.

Previous studies have reported that basal blood glucocorticoid levels in offspring are elevated by various factors, such as preterm birth, embryonic protein deficiency, prenatal stress, and early postnatal stress (early weaning and maternal separation). The steroid synthesis inhibitor metyrapone normalized the abnormalities caused by glucocorticoids. Our embryonic low-carbohydrate, calorie restricted diet did not affect the basal blood corticosterone levels in offspring, but significantly increased after a high-fat diet exposure. The difference from the previous reports that affect the basal level of glucocorticoid is considered to be that embryonic hypoglycemic stress is relatively mild stress. The Predictive adaptive response hypothesis is thought to make a trade-off that alters the metabolic and endocrine systems to protect brain size. It can be thought that the brain was protected by a trade-off in the mild stress of sugar restriction of dams. However, when a mismatch such as a high-fat diet occurs, it is possible that the abnormality cannot be withstood and the abnormality appears. Therefore, it is speculated that the basal blood corticosterone concentration was not affected and showed a high level after a high-fat diet. In the future, it is necessary to investigate the mechanism that causes embryonic programming of glucocorticoid feedback due to the difference in stress intensity.

5\. Although the authors demonstrate that glucocorticoids is involved in increased BP induced by postnatal high-fat diet in LBW newborns, these findings are not new, as glucocorticoids have been widely reported to be involved in programming of hypertension in adult animal studies.

\>According to the reviewer's comment, we rewritten as finding that the mechanism of elevated blood pressure in high-fat diet-exposed low-birth-weight rats is associated with abnormal glucocorticoid feeder back due to increased miR-449a expression in the pituitary. We also changed the title to "Elevated blood pressure in high-fat diet-exposed low birthweight rat offspring is most likely caused by elevated glucocorticoid levels due to abnormal pituitary negative feedback"

6\. The authors report the absence of pathological findings in the kidney and aorta as well as the elevation of blood aldosterone levels, indicated that renal and vascular diseases may not play a causative role in the development of hypertension in fetal low-carbohydrate and calorie-restricted rats. A potential mechanism for increased BP should be discussed in light of the negative findings in the renal and vasculature, considering the findings are contrary to what is observed in premature babies and other models of programming.

\>We understand that low birth weight infants have different mechanisms of increasing blood pressure in preterm and term infants. Our rat model is a term model because the gestational age was not shortened. As mentioned in the second paragraph of the discussion, we interpret that the glomerular number was not affected in our model because the number of glomeruli is strongly influenced by gestational age. Regarding the effects of nutrients in the uterus, we are planning an experiment because it is necessary to examine in detail how the carbohydrate restriction of the mother rat affected the amino acid composition of placental blood. We have added to the third paragraph of the discussion. It has been shown that the effects of glucocorticoids are affected not only during the embryonic period but also during postnatal stress. In the fourth comment from the reviewer, we added some thought to the involvement of glucocorticoids in blood pressure control in LBW rats.
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PLOS ONE

Dear Dr. Nemoto,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points still raised by reviewer 1.

Please submit your revised manuscript by Sep 21 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Michael Bader

Academic Editor

PLOS ONE
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The following concerns remain:

Weight at birth equals \~58 per group. This data should be presented as an average weight at birth per litter for the pups utilized for additional studies (excludes those culled).

Did average birth weight per litter for all viable pups (culled and utilized for additional studies) differ from average birth weight per litter for pups used for additional studies (excludes culled).

Methods needs to describe on page 6 the number of pups separated at 5 weeks of age that are in each experimental and dietary group.

A major concern is that after weaning, pups from all litters were mixed. Thus, can the authors ensure that only one pup per sex per litter was present in each study group versus multiple pups from the same litter included in the same dietary group. This is imperative in order to ensure a "programming" effect versus a "litter" effect.

Conclusions included on Page 11 within the first paragraph of the discussion that report an absence of pathological changes in the kidney and aorta (a non-resistance vessel) indicates a lack of involvement of renal and vascular disease as a component in the etiology of hypertension in this model is quite a stretch.

Conclusions that the mechanisms in this model differ from preterm infants is not unusual as this is not a model of preterm birth (line 287-288).

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer \#1: The following concerns remain:

Weight at birth equals \~58 per group. This data should be presented as an average weight at birth per litter for the pups utilized for additional studies (excludes those culled).

Did average birth weight per litter for all viable pups (culled and utilized for additional studies) differ from average birth weight per litter for pups used for additional studies (excludes culled).

\>The weights of all offspring used in the experiment are shown in Supplementary table 2. Female rats were not used in the experiment, but there was no difference between the average weight including female rats and the average weight of male rats (used in the experiment).

Methods needs to describe on page 6 the number of pups separated at 5 weeks of age that are in each experimental and dietary group.

\>According to the reviewer's comment, the number of rats was revised. We used control and LC offspring (46 rats each) divided into two groups (23 rats each); a standard diet and a high-fat diet.

A major concern is that after weaning, pups from all litters were mixed. Thus, can the authors ensure that only one pup per sex per litter was present in each study group versus multiple pups from the same litter included in the same dietary group. This is imperative in order to ensure a "programming" effect versus a "litter" effect.

\>We randomly mixed rat pups and used them in the experiment, but divided them so that each group contained one offspring from 10 dams. For example, the systolic blood pressure shows a mean blood pressure of 15 rats with 1 offspring from LC dam\# 1- \#5 plus 2 offspring from LC dam\#6 - \#10. The systolic blood pressure of a high fat diet exposed-offspring from LC dam \#6 was 150.1 mmHg in one and 165.8 mmHg in the other. The high fat diet exposed-offspring from LC dam \#7 was 146.1 mmHg on one and 154.0 mmHg on the other. They were higher than those of high fat diet exposed-control offspring. In other words, blood pressure does not increase only in the group born from a particular dam, and low birth weight rat pups due to fetal malnutrition tend to have increased blood pressure when exposed to a high-fat diet after birth. All data (including the dam ID) is available on figshare.com (<https://doi.org/10.6084/m9.figshare.12644165>).

Conclusions included on Page 11 within the first paragraph of the discussion that report an absence of pathological changes in the kidney and aorta (a non-resistance vessel) indicates a lack of involvement of renal and vascular disease as a component in the etiology of hypertension in this model is quite a stretch.

Conclusions that the mechanisms in this model differ from preterm infants is not unusual as this is not a model of preterm birth (line 287-288).

\>According to reviewer's comment, we revised sentence in discussion section to "renal and vascular diseases may not play a causative role in the development of hypertension in our full-term fetal low-carbohydrate and calorie-restricted rat model." (Changed to line 282-283)
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Dear Dr. Nemoto,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Michael Bader

Academic Editor

PLOS ONE
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Dear Dr. Nemoto:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Michael Bader

Academic Editor

PLOS ONE
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